These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15948113)

  • 1. Stromal elastosis in papillary thyroid carcinomas.
    Kondo T; Nakazawa T; Murata S; Katoh R
    Hum Pathol; 2005 May; 36(5):474-9. PubMed ID: 15948113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastosis in lung carcinoma: Immunohistochemical, ultrastructural and clinical studies.
    Fukushima M; Fukuda Y; Kawamoto M; Yamanaka N
    Pathol Int; 2000 Dec; 50(12):1004-13. PubMed ID: 11123770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elastosis in breast carcinoma: I. Immunohistochemical characterization of elastic fibres.
    Mera SL; Davies JD
    J Pathol; 1987 Feb; 151(2):103-10. PubMed ID: 3033189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elastosis in breast--correlation with epithelial proliferation in benign disease and carcinomatous growth.
    Khatun N; Arihiro K; Inai K
    Hiroshima J Med Sci; 1992 Dec; 41(4):87-100. PubMed ID: 1293074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression and role of serum response factor in papillary carcinoma of the thyroid.
    Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
    Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
    Roth LM; Miller AW; Talerman A
    Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of intratumoural variations in elastosis grades and the oestrogen receptor status of human breast carcinomas.
    Giri DD; Lonsdale RN; Dangerfield VJ; Harris SC; Parsons MA; Underwood JC
    J Pathol; 1987 Apr; 151(4):297-303. PubMed ID: 3585588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin expression in elastotic cuffs of invasive ductal carcinoma of the breast.
    Melis M; Baiocchini A; Soda G; Bosco D
    Pathol Res Pract; 1997; 193(7):479-84. PubMed ID: 9342753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis.
    Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O
    Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 expression in papillary microcarcinoma of the thyroid.
    Cvejic D; Savin S; Petrovic I; Paunovic I; Tatic S; Krgovic K; Havelka M
    Histopathology; 2005 Aug; 47(2):209-14. PubMed ID: 16045783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
    Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
    Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
    Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
    J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between pure papillary and follicular variant in papillary thyroid carcinoma.
    Yuksel O; Kurukahvecioglu O; Ege B; Ekinci O; Aydin A; Poyraz A; Tezel E; Taneri F
    Endocr Regul; 2008 Mar; 42(1):29-33. PubMed ID: 18333702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
    Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
    Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in 73 human thyroid tumors.
    Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
    Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
    Cvejic DS; Savin SB; Petrovic IM; Paunovic IR; Tatic SB; Havelka MJ
    Head Neck; 2005 Dec; 27(12):1049-55. PubMed ID: 16155918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
    El Demellawy D; Nasr AL; Babay S; Alowami S
    Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair.
    Cirello V; Recalcati MP; Muzza M; Rossi S; Perrino M; Vicentini L; Beck-Peccoz P; Finelli P; Fugazzola L
    Cancer Res; 2008 Oct; 68(20):8482-8. PubMed ID: 18922922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.